查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1591984

免疫沉淀市场：依产品类型、最终用户划分 - 2025-2030 年全球预测

Immunoprecipitation Market by Product (Accessories, Beads, Kits), Type (Chromatin Immunoprecipitation, Co-Immunoprecipitation, Individual Immunoprecipitation), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年免疫沉淀市场价值为13.6亿美元，预计2024年将达16.4亿美元，复合年增长率为20.78%，预计到2030年将达到51.3亿美元。

免疫沉淀 (IP) 是分子生物学中的一项重要技术，用于利用抗体-抗原相互作用从混合物中分离特定抗原。它的价值在于其精製蛋白质和核酸的能力，这对于蛋白质表现分析、基因表现研究和转译后修饰研究等应用至关重要。该过程在製药和生物技术等不同领域至关重要，并且在药物开发和诊断研究中很有用。市场成长的推动因素包括研发投资的增加、蛋白质体学的进步以及需要在微妙的分子层面上进行洞察的慢性疾病数量的增加。开发自动化系统并生产更有效率、高性能的抗体可以加快常规实验程序并提高精度。公司可以透过投资合作研究、专注于个人化医疗以及针对新兴市场提供创新且具有成本效益的解决方案来利用这些机会。然而，这个市场面临一些限制，例如与试剂和抗体相关的高成本、对熟练人员的需求以及维持复杂生物样本的特异性和产量的挑战。由于该细分市场对技术发展高度敏感，创新应专注于提高抗体特异性、改进精製技术以及整合人工智慧和机器学习以优化资料分析和预测建模。非侵入性采样技术和新型生物标记的研究也可能释放新的可能性。儘管市场竞争激烈，但开拓的时机已经成熟，趋势以将 IP 与质谱和次世代定序等互补技术相结合的整合解决方案为中心。企业应保持敏捷性，跟上技术和监管变化的步伐，同时培养与学术机构和高科技公司的伙伴关係，以推动突破性创新。解决当前自动化和可重复性方面的差距对于持续成长和保持竞争优势至关重要。

主要市场统计
基准年[2023] 13.6亿美元
预计年份 [2024] 16.4亿美元
预测年份 [2030] 51.3亿美元
复合年增长率（%） 20.78%

市场动态：揭示快速发展的免疫沉淀市场的关键市场洞察

供需的动态交互作用正在改变免疫沉淀市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 扩大免疫沉淀试验在中枢神经系统疾病的应用
    • 生命科学实验和研究活动增加
    • 改良染色质免疫通讯协定的开发
  • 市场限制因素
    • 蛋白质精製替代技术的存在
  • 市场机会
    • 免疫沉淀技术的进展
    • 政府及各行业加大投入
  • 市场问题
    • 研究抗体品质问题

波特五力：驾驭免疫沉淀市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点，避免潜在的挑战，确保更强大的市场地位。

PESTLE分析：了解免疫沉淀市场的外部影响

外部宏观环境因素在塑造免疫沉淀市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解免疫沉淀市场的竞争格局

对免疫沉淀市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：免疫沉淀市场供应商绩效评估

FPNV定位矩阵是评估免疫沉淀市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：规划免疫沉淀市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，免疫沉淀市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：详细检视当前市场环境，主要企业的广泛资料，评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、主要产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3. 塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 扩大免疫沉淀试验在中枢神经系统疾病的应用
      • 生命科学实验和研究活动增加
      • 改良染色质免疫通讯协定的开发
    • 抑制因素
      • 蛋白质精製替代技术的存在
    • 机会
      • 免疫沉淀技术的进展
      • 政府及各行业加大投入
    • 任务
      • 研究抗体品质问题
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章免疫沉淀市场：副产品

  • 介绍
  • 配件
    • 一抗
    • 二抗
  • 珠
    • 琼脂糖珠
    • 缓衝
    • 磁珠
  • 套件
  • 试剂

第七章免疫沉淀市场：依类型

  • 介绍
  • 染色质免疫沉淀
  • 免疫共沉淀
  • 个体免疫沉淀
  • RNA免疫沉淀

第八章免疫沉淀市场：依最终用户分类

  • 介绍
  • 学术研究所
  • 合约研究组织
  • 製药和生物技术公司

第九章美洲免疫沉淀市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太免疫沉淀市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲免疫沉淀市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbkine Scientific Co., Ltd
  • Abcam PLC
  • Axil Scientific Pte Ltd.
  • Bio-Rad Laboratories, Inc.
  • BioLegend, Inc. by PerkinElmer Inc.
  • Cell Signaling Technology, Inc.
  • Creative Biomart Inc.
  • Cytoskeleton, Inc.
  • EpiGentek Group Inc.
  • Geno Technology, Inc.
  • LifeSpan BioSciences, Inc.
  • MyJoVE Corporation
  • Proteintech Group, Inc.
  • Sino Biological Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-43676CF42C5B

The Immunoprecipitation Market was valued at USD 1.36 billion in 2023, expected to reach USD 1.64 billion in 2024, and is projected to grow at a CAGR of 20.78%, to USD 5.13 billion by 2030.

Immunoprecipitation (IP) is a key technique in molecular biology used to isolate a specific antigen from a mixture, utilizing an antibody-antigen interaction. Its value lies in its ability to purify proteins or nucleic acids, making it essential for applications such as protein expression analysis, gene expression studies, and post-translational modification investigations. The procedure is pivotal across diverse sectors like pharmaceuticals and biotechnology, where it aids in drug development and diagnostic research. Market growth is fueled by increasing R&D investments, advancements in proteomics, and the rising prevalence of chronic diseases requiring nuanced molecular insights. Opportunities abound in developing automated systems and creating more efficient, high-throughput antibodies, which can expedite routine lab procedures and enhance accuracy. Companies can harness these opportunities by investing in collaborative research, focusing on personalized medicine, and targeting emerging markets with innovative, cost-effective solutions. However, the market faces limitations such as high costs associated with reagents and antibodies, a requirement for skilled personnel, and challenges in maintaining specificity and yield in complex biological samples. As the sector is highly sensitive to technical developments, innovation should focus on enhancing antibody specificity, refining purification techniques, and integrating AI and machine learning to optimize data analysis and predictive modeling. Research into non-invasive sampling techniques and novel biomarkers could also unlock new potentials. The immunoprecipitation market is competitive but ripe for exploration, with trends pointing towards integrated solutions that combine IP with complementary technologies like mass spectrometry and next-generation sequencing. Businesses should remain agile, staying abreast of technological and regulatory changes, while fostering partnerships with academic institutions and tech companies to drive groundbreaking innovations. Addressing the current gaps in automation and reproducibility will be critical for sustained growth and maintaining a competitive edge.

KEY MARKET STATISTICS
Base Year [2023] USD 1.36 billion
Estimated Year [2024] USD 1.64 billion
Forecast Year [2030] USD 5.13 billion
CAGR (%) 20.78%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Immunoprecipitation Market

The Immunoprecipitation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing applications of immunoprecipitation testing in central nervous disorders
    • Rise in the number of life science experiments and research activities
    • Development of improved protocols for chromatin immunoprecipitation
  • Market Restraints
    • Presence of alternative technologies for protein purification
  • Market Opportunities
    • Advancements in immunoprecipitation techniques
    • Rising investments by governments and various industries
  • Market Challenges
    • Issues related to quality over research antibodies

Porter's Five Forces: A Strategic Tool for Navigating the Immunoprecipitation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Immunoprecipitation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Immunoprecipitation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Immunoprecipitation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Immunoprecipitation Market

A detailed market share analysis in the Immunoprecipitation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Immunoprecipitation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Immunoprecipitation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Immunoprecipitation Market

A strategic analysis of the Immunoprecipitation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Immunoprecipitation Market, highlighting leading vendors and their innovative profiles. These include Abbkine Scientific Co., Ltd, Abcam PLC, Axil Scientific Pte Ltd., Bio-Rad Laboratories, Inc., BioLegend, Inc. by PerkinElmer Inc., Cell Signaling Technology, Inc., Creative Biomart Inc., Cytoskeleton, Inc., EpiGentek Group Inc., Geno Technology, Inc., LifeSpan BioSciences, Inc., MyJoVE Corporation, Proteintech Group, Inc., Sino Biological Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Immunoprecipitation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Accessories, Beads, Kits, and Reagents. The Accessories is further studied across Primary Antibodies and Secondary Antibodies. The Beads is further studied across Agarose Beads, Buffers, and Magnetic Beads.
  • Based on Type, market is studied across Chromatin Immunoprecipitation, Co-Immunoprecipitation, Individual Immunoprecipitation, and RNA Immunoprecipitation.
  • Based on End-User, market is studied across Academic & Research Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing applications of immunoprecipitation testing in central nervous disorders
      • 5.1.1.2. Rise in the number of life science experiments and research activities
      • 5.1.1.3. Development of improved protocols for chromatin immunoprecipitation
    • 5.1.2. Restraints
      • 5.1.2.1. Presence of alternative technologies for protein purification
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in immunoprecipitation techniques
      • 5.1.3.2. Rising investments by governments and various industries
    • 5.1.4. Challenges
      • 5.1.4.1. Issues related to quality over research antibodies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Immunoprecipitation Market, by Product

  • 6.1. Introduction
  • 6.2. Accessories
    • 6.2.1. Primary Antibodies
    • 6.2.2. Secondary Antibodies
  • 6.3. Beads
    • 6.3.1. Agarose Beads
    • 6.3.2. Buffers
    • 6.3.3. Magnetic Beads
  • 6.4. Kits
  • 6.5. Reagents

7. Immunoprecipitation Market, by Type

  • 7.1. Introduction
  • 7.2. Chromatin Immunoprecipitation
  • 7.3. Co-Immunoprecipitation
  • 7.4. Individual Immunoprecipitation
  • 7.5. RNA Immunoprecipitation

8. Immunoprecipitation Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic & Research Institutes
  • 8.3. Contract Research Organizations
  • 8.4. Pharmaceutical & Biotechnology Companies

9. Americas Immunoprecipitation Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Immunoprecipitation Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Immunoprecipitation Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbkine Scientific Co., Ltd
  • 2. Abcam PLC
  • 3. Axil Scientific Pte Ltd.
  • 4. Bio-Rad Laboratories, Inc.
  • 5. BioLegend, Inc. by PerkinElmer Inc.
  • 6. Cell Signaling Technology, Inc.
  • 7. Creative Biomart Inc.
  • 8. Cytoskeleton, Inc.
  • 9. EpiGentek Group Inc.
  • 10. Geno Technology, Inc.
  • 11. LifeSpan BioSciences, Inc.
  • 12. MyJoVE Corporation
  • 13. Proteintech Group, Inc.
  • 14. Sino Biological Inc.
  • 15. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. IMMUNOPRECIPITATION MARKET RESEARCH PROCESS
  • FIGURE 2. IMMUNOPRECIPITATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. IMMUNOPRECIPITATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. IMMUNOPRECIPITATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. IMMUNOPRECIPITATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. IMMUNOPRECIPITATION MARKET DYNAMICS
  • TABLE 7. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY PRIMARY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY SECONDARY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY AGAROSE BEADS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY BUFFERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY CHROMATIN IMMUNOPRECIPITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY CO-IMMUNOPRECIPITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY INDIVIDUAL IMMUNOPRECIPITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY RNA IMMUNOPRECIPITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 237. IMMUNOPRECIPITATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 238. IMMUNOPRECIPITATION MARKET, FPNV POSITIONING MATRIX, 2023